Abciximab as a bridging strategy to overcome morphine –prasugrel interaction in STEMI patients

ConclusionThe infusion of the GPIIb/IIIa receptor blocker abciximab allows immediate and efficient platelet inhibition in STEMI patients concomitantly receiving the oral ADP receptor blocker prasugrel and morphine.

Source: British Journal of Clinical Pharmacology - July 23, 2016 Category: Drugs & Pharmacology Authors: Jolanta M. Siller ‐Matula, Simon Specht, Jacek Kubica, Dimitrios Alexopoulos, Raffaele De Caterina, Eva‐Luise Hobl, Bernd Jilma, Günter Christ, Irene M. Lang Tags: DRUG INTERACTIONS Source Type: research